ASCO® GU 2024 Insights: "Association of DAZL Expression With Risk of Recurrence in Clinical Stage 1 Testicular Germ Cell Tumors"
By
Dana-Farber Cancer Institute
FEATURING
Alok Tewari
By
Dana-Farber Cancer Institute
FEATURING
Alok Tewari
Login to view comments.
Click here to Login